The hidden epidemic: the prevalence and impact of concurrent liver diseases in patients undergoing liver transplantation in Australia and New Zealand.
10.1097/txd.0000000000001345 · 2022
Unresolved referenced work
Kept as external metadata until matched
Cancer control measures have prevented 230,000 deaths in Australia since the mid-1980s.
10.1016/j.anzjph.2025.100252 · 2025
Nonalcoholic fatty liver disease burden: Australia, 2019-2030.
10.1111/jgh.15009 · 2020
Cirrhosis in primary practice: many patients remain potentially undiagnosed and are not receiving liver cancer surveillance.
10.1111/jgh.16782 · 2025
The global economic burden of cirrhosis and other chronic liver diseases: a health-augmented macroeconomic modeling study.
10.1097/hc9.0000000000000882 · 2026
Increasing hospitalization rates for cirrhosis: overrepresentation of disadvantaged Australians.
10.1016/j.eclinm.2019.05.007 · 2019
Age, period and cohort trends in hospital admissions for alcohol-related liver disease in Australia, 1993-2020.
10.1111/dar.14063 · 2025
Healthcare utilisation and costing for decompensated chronic liver disease hospitalisations at a Victorian network.
10.1111/imj.15962 · 2023
Increasing health care burden of chronic liver disease compared with other chronic diseases, 2004-2013.
10.1053/j.gastro.2018.05.032 · 2018
Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.
10.1016/j.jhep.2005.10.013 · 2006
HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: a meta-analysis.
10.1016/j.jhep.2022.01.023 · 2022
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.
10.1016/s0140-6736(18)31875-0 · 2019
A randomized multicenter trial of a chronic disease management intervention for decompensated cirrhosis. The Australian Liver Failure (ALFIE) trial.
10.1097/hep.0000000000000862 · 2025
Optimisation of hepatocellular carcinoma surveillance in patients with viral hepatitis: a quality improvement study.
10.1111/imj.12166 · 2013
Hepatocellular carcinoma surveillance in Australia: current and future perspectives.
10.5694/mja2.52442 · 2024
A shared model of care for compensated cirrhosis is safe and acceptable to patients and general practitioners.
2026
Unresolved referenced work
Kept as external metadata until matched
Surveillance for liver cancer in primary care: a systematic review of the evidence.
10.31128/ajgp-11-22-6619 · 2023
Lessons from the implementation of the health care homes program.
10.5694/mja2.51537 · 2022
Model for integrated care for chronic disease in the Australian context: Western Sydney integrated care program.
10.1071/ah18152 · 2019
Improving primary care in Australia through the Australian primary care collaboratives program: a quality improvement report.
10.1136/bmjqs-2011-000165 · 2012
Implementing a scalable, personalised, behaviour change digital health programme in primary care for type 2 diabetes treatment: the SCALE cluster-randomised study protocol.
10.1136/bmjopen-2025-101531 · 2025
Learning from the implementation of a quality improvement intervention in Australian general practice: a qualitative analysis of participants views of a CVD preventive care project.
10.1186/s12875-022-01692-0 · 2022
Unresolved referenced work
Kept as external metadata until matched
The IC3 trial: protocol for a multicentre individually randomised controlled trial to compare a cirrhosis detection and hepatocellular carcinoma surveillance pathway vs usual care in Australian general practice for 45-75 years old with risk factors for chronic liver disease.
10.1186/s13063-025-09037-9 · 2025
Assessment of metabolic dysfunction-associated fatty liver disease in primary care: a consensus statement summary.
10.5694/mja2.70008 · 2025
